Rasmus Sejersten Ripa

Rasmus Sejersten Ripa

Postdoc, Clinical Associate Professor


  1. 2006
  2. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention

    Wang, Y., Johnsen, H. E., Mortensen, S., Bindslev, L., Ripa, Rasmus Sejersten, Haack-Sørensen, M., Jørgensen, E., Fang, W. & Kastrup, J., Jun 2006, In: Heart. 92, 6, p. 768-74 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial)

    Sejersten, M., Ripa, Rasmus Sejersten, Maynard, C., Wagner, G. S., Andersen, H. R., Grande, P., Mortensen, L. S. & Clemmensen, P., 1 Mar 2006, In: American Journal of Cardiology. 97, 5, p. 611-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Jørgensen, E., Wang, Y., Thune, J. J., Nilsson, J. C., Søndergaard, Lars, Johnsen, H. E., Køber, Lars Valeur, Grande, P. & Kastrup, J., 2006, In: Circulation. 113, 16, p. 1983-92 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2005
  6. Consideration of the total ST-segment deviation on the initial electrocardiogram for predicting final acute posterior myocardial infarct size in patients with maximum ST-segment deviation as depression in leads V1 through V3. A FRISC II substudy

    Ripa, Rasmus Sejersten, Holmvang, L., Maynard, C., Sejersten, M., Clemmensen, P., Grande, P., Lindahl, B., Lagerqvist, B., Wallentin, L. & Wagner, G. S., Jul 2005, In: Journal of Electrocardiology. 38, 3, p. 180-6 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease

    Wang, Y., Tägil, K., Ripa, Rasmus Sejersten, Nilsson, J. C., Carstensen, S., Jørgensen, E., Søndergaard, L., Hesse, B., Johnsen, H. E. & Kastrup, J., 28 Apr 2005, In: International Journal of Cardiology. 100, 3, p. 477-83 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Comparison between human and automated electrocardiographic waveform measurements for calculating the Anderson-Wilkins acuteness score in patients with acute myocardial infarction

    Ripa, Rasmus Sejersten, Persson, E., Hedén, B., Maynard, C., Christian, T. F., Hammill, S., Pahlm, O. & Wagner, G. S., Apr 2005, In: Journal of Electrocardiology. 38, 2, p. 96-9 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer

    Ripa, Rasmus Sejersten, Katballe, N., Wikman, F., Jäger, A. C., Bernstein, I., Orntoft, T., Schwartz, M., Nielsen, F. C. & Bisgaard, M. L., 15 Feb 2005, In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 570, 1, p. 89-96 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Safety of bone-marrow stem cell mobilisation induced by granulocyte-colony stimulating factor: Clinical 30 days blinded results from the stem cells in myocardial infarction (STEMMI) trial

    Ripa, Rasmus Sejersten, Wang, Y., Jørgensen, E., Johnsen, H. E., Grande, P. & Kastrup, J., 2005, In: HeartDrug. 5, p. 177-82 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2004
  12. Mutation analysis of the adenomatous polyposis coli (APC) gene in Danish patients with familial adenomatous polyposis (FAP)

    Bisgaard, M. L., Ripa, Rasmus Sejersten & Bülow, S., May 2004, In: Human Mutation. 23, 5, p. 522

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype

    Bisgaard, M. L., Ripa, Rasmus Sejersten, Knudsen, A. L. & Bülow, S., Feb 2004, In: Gut. 53, 2, p. 266-70 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 45867987